The Jackson Laboratory
Biomedical research, education, mouse models and services for scientists and the global biomedical community
Highlights
- New on EvolcAdded 2026-11-13
Recent signals
What changed at The Jackson Laboratory in the last 6 months, newest first. Each line links to its public source.
- 13 Nov 2026 Leadership hire · Hiring Director, Public Relations & Communications thejacksonlaboratory.wd503.myworkdayjobs.com
About The Jackson Laboratory
The Jackson Laboratory is an independent nonprofit biomedical research organization studying genetic and molecular factors underlying human disease. It conducts research and provides mouse models, research tools, data resources, education and preclinical services.
Its customers and users include biomedical researchers and organizations that use its models, data and services, as well as students and clinicians who take part in its education programs.
Founded in 1929, JAX has campuses in Maine, Connecticut and California, and a presence in Japan. It reports 3,000 employees and more than 60 faculty members. Its research and faculty hiring includes positions in Connecticut and Maine.
Product: Biomedical research, mouse models, data resources, education programs and preclinical research services.
Jobs at The Jackson Laboratory
More biotech & pharma companies
Tonix Pharmaceuticals
Develops investigational medicines and vaccines for patients with chronic conditions, infectious diseases and rare disordersNew on EvolcValo Health
AI-enabled drug discovery and development for pharmaceutical and biotech partnersNew on EvolcVaxcyte
Clinical-stage vaccine developer making pneumococcal, Group A Strep and Shigella vaccines for children and at-risk adultsRemote-friendlyViatris
Global pharmaceutical company supplying generic, branded and innovative medicines to patients and healthcare markets worldwideWatchmaker Genomics
Enzymes and reagents for NGS library prep and molecular diagnostics, sold to life science researchers and diagnostics developersRemote-friendlyZentalis
Clinical-stage oncology company developing an oral WEE1 inhibitor, azenosertib, for platinum-resistant ovarian cancerNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Website resourcedeclared script/iframe or software asset
- Response headerserver
Frontend frameworks
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Next.js
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.